Guide · btccalcs.com
Is MSTR overvalued?
Published 2026-06-23
Short answer: as of June 2026, MSTR is not overvalued if — and only if — Strategy keeps growing BTC per share faster than shares outstanding, and the market keeps paying a premium above Bitcoin NAV for that accretion. At the current mNAV, MSTR trades meaningfully above the value of its 214,246 BTC, so buying MSTR is buying spot Bitcoin plus a reflexivity bet on continued accretive issuance and continued premium. Remove either leg and MSTR converges toward (or below) NAV; keep both and it compounds faster than spot BTC. That is why standard DCF doesn't price MSTR — the premium is endogenous to the strategy, not an output of cash flows.
Mechanism
At mNAV = 1×, MSTR is Bitcoin with operating cost drag. Above 1×, equity issuance is BTC-per-share accretive, and the higher the multiple the more accretive each dollar raised. Below 1×, issuance dilutes BTC per share. The break-even condition for accretive issuance is: Issue price per share / (BTC price × BTC per share) > 1. From there a simple scenario tree falls out: BTC bull with premium holding (best case, compounding accretion), BTC bull with premium compressing (good in absolute terms, weak relative to spot BTC), BTC flat (slow grind, debt service matters), BTC bear (premium collapse risk plus convertible note pressure). Strategy reported 214,246 BTC as of the Q1 2025 10-Q, which anchors the NAV side of every scenario.
Detail
Governance and debt. Strategy carries convertible notes whose service and covenant structure matters independent of BTC price. A scenario where BTC trades sideways for two years while the notes accrue interest is a different risk than a BTC drawdown, and both need to be modeled separately from the premium thesis.
The CEBE read. CEBE (Core Earnings Before Bitcoin Expenses) captures what the legacy software business contributes to covering operating costs and interest. A thin or negative CEBE means the cost stack is being funded from equity issuance or BTC sales, which makes the company more sensitive to capital-market access.
Why reflexivity makes MSTR hard to value with a DCF. The premium is endogenous to the acquisition strategy: the premium funds the issuance that justifies the premium. A standard discounted cash-flow model has no place to put that loop, which is why most MSTR analyses default to scenario trees rather than point estimates.
What would make the premium justified. A multi-year track record of BPS accretion above dilution, CEBE comfortably above debt service, and capital-market access intact through a BTC drawdown. What would make it unjustified: mNAV compressing toward 1× with no slowdown in dilution, CEBE turning thin while interest expense rises, or convertible note holders losing confidence.
Sources
Related
FAQ
What this leaves out. Educational content based on public filings and market data as of the published date. Not investment, accounting, tax, or legal advice. Verify all figures against primary sources before acting.